Main function Subfunction Purpose
Center of metabolism energy supply of the body glucose uptake and release ketone body production urea production amino acid uptake and release lipid processing biosynthesis and biodegradation
Center of defense
Control station of the hormonal system plasma protein synthesis and degradation bile formation xenobiotic metabolism phagocytosis and biochemical elimination of foreign macromolecules and macromolecular aggregates elimination of tumor cells inactivation and elimination of hormones and mediators synthesis and release of (pro)hormones and mediators
Blood reservoir active blood storage passive blood storage The liver is the center of intermediary metabolism, a center of defense, a control center for the hormonal system and a blood reservoir (Table 1 ). The many diverse hepatic functions are provided by parenchymal and non-parenchymal cells ( Fig. 1) and are regulated by substrate concentrations in blood, circulating hormone levels, autonomic hepatic nerves and the biomatrix. Moreover, the parenchymal cells can be under the control of the non-parenchymal cells and vice versa. It is the aim of this review first to give a short introduction into the anatomy of hepatic innervation and a brief overview on in vivo studies of hepatic nerve functions, then to summarize the present knowledge about the metabolic and hemodynamic effects, the mechanism of action and the function of the hepatic nerves as studied in the isolated perfused liver.
Anatomy of hepatic innervation
This section provides only a short overview of hepatic innervation. Additional and more detailed information is avaiable in other publications [5 -111.
Extrinsic inner vat ion
Nerves innervating the liver include afferent and efferent, sympathetic, parasympathetic and peptidergic components (Fig. 2) . The hepatic Sympathetic fibers are derived from the splanchnic nerves, the parasympathetic fibers from the vagus nerves. Spianchnic, vagal and sometimes also phrenic nerves enter the liver primarily with the hepatic artery, portal vein and bile duct. Some fibers are not associated with the hepatic vasculature and enter the liver via the lesser omentum or the hepatic vein. Sympathetic and parasympathetic nerves form two separate, but communicating, plexuses; the anterior plexus around the hepatic artery is composed of fibers originating from the celiac ganglion and anterior vagus, the posterior plexus around the portal vein and bile duct is formed by fibers from the celiac ganglion and right vagus.
The sensory afferent nerves were estimated to represent up to 90% of the fibers of the abdominal vagus and about 50% of sympathetic fibers in the splanchnic nerve [ll] . Afferent vagal fibers project primarily to the left nodose ganglion, then to the medial portion of.the left solitary nucleus [12] . Afferent splanchnic fibers also project to the left solitary nucleus [13] . Efferent sympathetic nerves originate in the ventromedial hypothalamus and Parasympathetic fibers in the lateral hypothalamus [14] (Fig. 2) . L, liver; P, pancreas; A, adrenals; Ins, insulin; Ggn, glucagon; A, adrenaline; NA. noradrenaline; GC, ganglion coeliacum; Th7(10), seventh(tenth) thoracai segment of the splanchnic nerve.
Intrinsic innervation
Many intrinsic nerves of the liver are associated with the arterial and portovenous vasculature-forming plexuses in the adventitia and terminating on smooth muscle cells [15, 161. Nerve endings have also been demonstrated on Kupffer cells, fat-storing cells and the hepatocytes [Il, 171. Whereas the density of the vascular innervation does not vary considerably [18] , the extent and distribution of intralobular innervation exhibit remarkable interspecies variations [15, 18, 191 . In the guinea pig and tree shrew, nearly all hepatocytes possess nerve contacts [18] , whereas in the rat only a few periportal hepatocytes are innervated [18, 191 . The extent of the intrinsic innervation of the parenchymal cells seems to be inversely correlated to the number of signal-propagating gap junctions, since in livers of the tree shrew and guinea pig only a low density [I 51, but in rat liver [I91 a high density of gap junctions has been demonstrated. Studies of primate liver [15] suggest that intralobular innervation is primarily, if not exclusively, monoaminergic. So far, a significant cholinergic innervation of the lobule has only been demonstrated in the guinea pig liver [I 1,201. Besides an adrenergic and a cholinergic innervation a peptidergic innervation has also been found in livers of various species. Vasoactive intestinal peptide could be demonstrated in the hilar region, substance P in the periportal area and neurotensin in the parenchymal region [21, 22] . Neuropeptide Y is apparently co-localized with noradrenaline in hepatic nerve terminals [23, 241 and was identified together with substance P and calcitonin-gene-related peptide in nerve fibers around lymphatic capillaries in the interconnective tissue of rat liver [25] . The functions of the petidergic innervation of the liver have not been studied so Par.
In vivo studies on the role of hepatic nerves
Many studies have been performed in living animals in order to assess the physiological role of the hepatic nerves. It is, however, far beyond the scope of this review to discuss these experiments in detail. They will be considered only briefly to provide a useful background to the studies with isolated perfused livers, reviewed in the next sections. More detailed reviews presenting the in-vivo data have been published recently [7, 11, [26] [27] [28] .
Acute metabolic and hemodynamic regulation by eJferent nerves
Efferent sympathetic hepatic nerves work in the frequency range 2 -20 Hz [29, 301 , the efferent parasympathetic fibers in the range 5 -15 Hz [31] . It is not known whether a change in the frequency range of sympathetic nerves can alter the ratio in which colocalized substances in nerve endings like neuropeptide Y [23, 241 can be released. The discharge rates of the nerves are regulated by the blood-glucose concentration via the central nervous system [ll] ; the frequency of parasympathetic nerves can be increased in vivo by taste stimulation [32] .
Metabolism. Efferent sympathetic fibers, connected to the liver, have been stimulated either in the ventromedial hypothalamus [33, 341, preganglionically [46] , a decrease in hepatic oxygen consumption in cats [48] and an overflow of noradrenaline into the hepatic vein in dogs [42] .
Efferent parasympathetic fibers connected to the liver have been stimulated either in the lateral hypothalamus [49] or preganglionically at the cervical left vagus nerve [41, 501. Stimulation increased hepatic glycogen synthesis in rabbits [50, 511 and reduced hepatic glucose output in chemically sympathectomized cats [52] .
Hemodynamics. Stimulation of the sympathetic splanchnic nerves reduced hepatic blood flow in cats and dogs [48, 53, 541 and lowered the blood volume in the hepatic capacitance vessels, thereby replenishing the systemic circulation. These effects were antagonized by circulating adenosine and glucagon 155,561. In cats, bile secretion was reduced by stimulation of the splanchnic nerve [57] . Stimulation of the hepatic branch of the vagus nerve opened previously closed sinusoids in the rat [58, 591 .
Chronic regulation by efferent nerves
There is also evidence that liver nerves are involved, not only in short-term, but also in long-term metabolic regulation. Local removal of sympathetic fibers decreased hepatic cholesterol synthesis, whereas destruction of the parasympathetic fibers increased hepatic cholesterol synthesis in rats [60] . Selec- tive hepatic vagotomy abolished the day/night rhythm of tyrosine aminotransferase [61] and reduced the cytochrome P450 content 1621 of the liver. Likewise, carbon tetrachloride-induced hepatic injury was aggravated by simultaneous stimulation of the ventromedial hypothalamus, causing an increased hepatic sympathicotonus [34] . Sympathetic denervation resulted in a hyperplasid of fiver fibroblasts [63] that could be antagonized by infusion of adenosine. Denervated livers showed a compensatory hypersensitivity to glucagon [64] and noradrenaline [65] .
Communication with other organs via afferent nerves
The importance of afferent hepatic nerves in the regulation of glucose homeostasis has been studied extensively by the group of Niijima [25, 26, [66] [67] [68] [69] and by others [70- [70] . The stimulation of insulin secretion by intraperitoneal administration of glucose was abolished [71] and the stimulation of arginine was enhanced [72] by hepatic vagotomy. Electrical stimulation of the afferent branch of the hepatic vagus nerve decreased insulin secretion [69] in anesthetized rats. All these data provide evidence for a direct neural control of pancreatic and adrenal functions by glucose sensors in the liver.
Effects of hepatic nerves in isolated perfused liver
For studies on the importance of liver nerves in the regulation of hepatic metabolism and hemodynamics, rat livers were perfused either via the portal vein only with a pressure of about 2 kPa 1731, or simultaneously via both the hepatic artery with a high pressure of about 13 kPa (20-40% of total (Table 2 ). In portally perfused mouse liver, stimulation of the hepatic nerves also increased glucose release [85] .
In hepatic-artery-plus-portal-vein-perfused rat liver, single separate stimulation of only the arterial plexus at the common hepatic artery caused 2 -3-fold greater metabolic changes in the glucose and lactate balance than stimulation of the portal plexus at the mesenteric vein (Fig. 3 ) [74]. The effects after single separate stimulation were additive to those after simultaneous separate stimulation, which in turn were the same as after joint stimulation of both plexuses in the liver hilus. The sympathetic actions on glucose and lactate balance, both i n portal-vein-perfused [86] and in hepatic-artery-plus-portalvein-perfused [74] livers, were half-maximal at a frequency of around 5 Hz, which is within the physiological range of frequencies of up to 20 Hz [29] .
h W i t h E r y t h r o c y t e s I B Without E r y t h r o c y t e s
Interactions between the hormonal and nervous systems were studied in portal-vein-perfused liver (Fig. 4) . In the presence of glucagon levels which enhanced glucose output and lactate uptake only submaximally, nerve stimulation altered the glucose and lactate balance to a similar extent as in controls [87] . Insulin, which under euglycemic conditions had no effect by itself, clearly reduced the nerve stimulation-dependent increase in glucose output without modifying the switch of lactate uptake to release [87, 88] . Noradrenaline, adrenaline [89] , vasopressin and angiotensin (Miura, H., Gardemann, A. , Rosa J. & Jungermann, K., unpublished results), which themselves caused about half-maximal alterations, inhibited the nerve stimulation-induced increase in glucose and lactate output with descending effectivity. Since these substances did not influence noradrenaline overflow, the inhibitory effects were apparently caused by a postsynaptic and not by a presynaptic mechanism.
NA

Hernodynamic effects of sympathetic nerves
In portal-vein-perfused livers, nerve stimulation reduced portal flow [73] . In hepatic-artery-plus-portal-vein-perfused livers, stimulation of the arterial plexus caused a drastic decrease in arterial flow and also in portal flow; conversely, stirnulation of the portal plexus led to a less pronounced decrease in portal flow and again a decrease in arterial flow (Fig. 3) [74]. The sum of the hemodynamic effects of single separate stimulations was greater than the effects of simultaneous separate or joint stimulation. Complex hemodynamic interactions between the hepatic artery and portal vein have also been observed in vivo [54, 901.
Sympathetic-nerve stimulation not only altered perfusion flow, but also the intrahepatic distribution of the perfusate; infusion of trypan blue 20 s after onset of nerve stimulation resulted in a heterogeneous staining of the liver both at the surface and in cross-sections, while it led to a homogeneous distribution in non-stimulated controls [82, 841. A redistribution of perfusion flow upon nerve stimulation was also detected in vivo in rats using X-ray angiography [91] and in dogs using heat-conduction measurements [92] ; it was, however, not observed in a study using radiolabelled microspheres [531.
A deeper insight into the function of the microcirculatory changes was provided by the observation in the perfused rat liver that, in periportal areas at the liver surface, the oxygen tension decreased immediately after stimulation of the arterial and portal plexuses, while, in contrast, in the perivenous zone it first increased sharply, then fell to low values [82 -841. The transient rise in the perivenous pOz was probably caused by oxygen-rich perfusate, which was squeezed out by the blood reservoirs of the liver from the periportal zone through the perivenous zone. A nerve-stimulation-dependent constriction of the sinusoids had been observed before in morphological studies with rat liver in vivo [93] .
The hemodynamic changes occurred within the physiological frequency range up to 20 Hz [29] with half-maximal effects around 1.5 Hz in portal-vein-perfused rat liver [86] and around 6 Hz in hepatic-artery-plus-portal-vein-perfused [74] rat liver. The latter value is similar to or higher than the corresponding values for glucose release. Thus, in the hepaticartery-plus-portal-vein-perfused and portal-vein-perfused liver, hepatic flow was less sensitive to hepatic nerve stimulation than glucose output. These results are in line with earlier studies in vivo [41, 43, 45, 53, 941 . Since hepatic flow changes, accompanied by an intrahepatic redistribution of flow, can be regarded to mirror the blood-reservoir function of the liver [86], these findings apparently show that acting as a blood reservoir is a liver function of lower priority than acting as a glucose store.
Metabolic effects of parasympathetic nerves
In portal-vein-perfused rat liver, parasympathetic stimulation (perivascular stimulation in the presence of the ablocker phentolamine and the 8-blocker propranolol) had no influence on basal glucose metabolism either under euglycemic or under hyperglycemic conditions [95] . However, in the presence of insulin which under hyperglycemic conditions caused a small enhancement of glucose utilization, parasympathetic stimulation led to a further increase in glucose uptake. In the presence of glucagon, which also stimulated glucose release under hyperglycemic conditions, parasympathetic stimulation antagonized the glucagon-mediated glucose output. This nerve effect could be mimicked by acetylcholine and was prevented by the parasympathetic antagonist atropine. Also, insulin could antagonize the glucagon-stimulated glucose release; parasympathetic-nerve stimulation in the presence of insulin was even more effective than either stimulus alone [95] .
Hemodynamic effects of parasympathetic nerves
In the liver perfused via the portal vein, parasympathetic nerve stimulation did not alter the perfusion flow [95] . In invivo studies it was observed that vagal stimulation opened sinusoids which had previously been closed [58, 591. It was speculated that parasympathetic nerves may not change the overall liver flow, but cause an extensive redistribution of hepatic blood [54] .
MECHANISM OF ACTION OF SYMPATHETIC HEPATIC NERVES
Signal propagation from the nerve cells to the effector cells
Noradrenaline release
The primary event following electrical stimulation of the hepatic sympathetic nerves is the release of noradrenaline from the varicosities at the nerve terminals. Noradrenaline is eliminated from its site of action by re-uptake into the nerve endings, degradation by the liver cells and diffusion into the vascular bed. The difference between noradrenaline release reuptake plus degradation can be measured as noradrenaline overflow into the hepatic vein, which reaches a maximum about 0.5 -1.5 min after the onset of stimulation [74, 861 (Fig. 3) . The release of noradrenaline from the nerve endings and thus the noradrenaline overflow and all effects of electrical-nerve stimulation are strictly dependent on the presence of extracellular calcium [73, 96, 971 . 
Parameters
Gap junction inhibitor 
in control experiments the noradrenaline-dependent glucose output was lowered to 70%. P < 0.01.
Metabolism
Noradrenaline action. The metabolic effects of sympathetic hepatic nerve stimulation are mediated via LX receptors. The increase in glucose, lactate and uric acid output can be inhibited by :he a-receptor blockers phentolamine or prazosin almost completely both in monovascular and bivascular perfusions [73 -761. A study of monovascular perfusion using the subtype-specific a,-receptor, a2-receptor, pl-receptor and p2-receptor blockers prazosin, yohimbine, metoprolol and butoxamine provided evidence only for the involvement of aladrenergic receptors in the signal chain of events, whereas a2, PI and p2 receptors seemed to play no role [75] . Yet, in liver perfused simultaneously via the hepatic artery and the portal vein, propranolol attenuated the nerve stimulation-dependent increase in glucose and lactate output, indicating that receptors, which were accessible only in the bivascular perfusion, had a permissive role in the regulation of carbohydrate metabolism by the sympathetic hepatic nerves [74] . This permissive action could not be attributed to a modulation by presynaptic receptors of noradrenaline and cotransmitter release from the nerve endings [75] .
Direct regulation of liver metabolism by hepatic nerves. The metabolic effects of hepatic sympathetic nerves could be mediated either directly by contact of the nerve endings with the hepatocytes or indirectly by the overflow of noradrenaline from the vasculature or by a hypoxia due to the flow reduction (Fig. 5) . These two indirect mechanisms could be excluded. Noradrenaline not taken up into the nerve endings at the smooth muscles of the vasculature and carried to the hepatocytes with the blood stream, should not reach the hepatocytes in perfusions with retrograde direction from the hepatic vein to the portal vein. Yet, metabolic alterations after nerve stimulation in retrograde perfusions were almost equal to those in orthograde perfusions [97] . In addition, circulating noradrenaline had no effect on glucose or lactate output in concentrations that could be expected to result from release of noradrenaline from the nerve endings into the circulation. The hypothesis that the metabolic effects of nerve stimulation were a mere consequence of an impaired sinusoidal circulation resulting in hepatocellular hypoxia could be dismissed, since the nerve-stimulation-elicited increase in glucose and lactate output remained nearly unaffected when the flow reduction was prevented by sodium nitroprusside [73, 971 or nifedipine [98] . Similarly, the nerve-stimulation-dependent formation of ketone bodies [78, 88] , allantoin and uric acid [76] , conjugation of xenobiotics [80] and secretion of bile [81] were independent of flow changes in contrast to the changes in urea, glutamine and ammonia balance [79] (not shown). Thus, hepatic sympathetic nerves seemed to regulate the metabolism of carbohydrates and ketone bodies or the conjugation of xenobiotics directly and the metabolism of nitrogenous compounds indirectly.
Involvement of gap junctions. The question was addressed as to whether every single hepatocyte is reached by the nerve endings or only some periportally located cells. In the latter case, the signal could be further propagated via gap junctions between hepatocytes. Large interspecies differences were found both on the basis of anatomical [15, 18, 191 and biochemical studies [99] . Thus, the liver parenchyma of guinea pig and tree shrew is densely innervated and has few gap junctions, whereas the parenchyma of the rat is scarcely innervated at the periportal borders of the acinus, but is rich in gap junctions [19] . Electrical stimulation of the hepatic nerves in these three species elicited about equal increases in glucose output, however, in guinea pig and three shrew livers, the noradrenaline content and its overflow were 6 -7-fold higher than in rat liver, in line with the denser innervation [99] . Thus, signal propagation via gap junctions might be of outstanding importance in rat liver. This was demonstrated by two approaches. (1) Rat liver regenerating after partial hepatectomy was found to contain a clearly reduced number of gap junctions [loo, 1011. After 67% partial hepatectomy, the liver remnant reached 59% of the original liver mdSS after 48 h, and 75% of the original liver mass after 72 h [102] , whereas gap junctions had not been redeveloped [loo, 1011. Stimulation of hepatic nerves in perfused rat liver resulted in a flow reduction and a noradrenaline overflow similar to that observed in control livers, indicating that the nerves were functioning [lo31 (Table 3) . Nevertheless, the stimulation-dependent increase in glucose output was reduced by 80%. Eleven days after partial hepatectomy, the gap junctions were re-expressed and the nerve-stimulation-mediated increase in glucose output reached control levels again. (2) Gap junctions were inhibited by the glycerrhetinic acid derivative carbenoxolone or low concentrations of the phorbol ester 4p-phorbol 12-myristate 13-acetate. Again, the nerve-stimulation-dependent increase in glucose output was inhibited by 50% and 80%, respectively [1041, whereas noradrenaline overflow was not significantly affected (Table 3) . Both studies together provide strong evidence that about 50% of the metabolic nerve effects in rat liver are mediated via signal propagation through gap junctions (see below and Fig. 8) . [106] . This led to the hypothesis, that eicosanoids might also play a role in the signal chain after nerve stimulation. Noradrenaline and/or other cotransmitters released from the nerve endings could stimulate prostanoid formation in nearby non-parenchymal liver cells. Prostanoids, in turn, might modulate metabolism in parenchymal cells (Fig. 5) . Indeed, the nerve-stimulation-dependent metabolic alterations could be inhibited in rat [115] and guinea pig [99] livers by the phospholipase A2 inhibitor brornophenacylbromide, which also inhibits prostaglandin Dz synthesis [116] , and by the cyclooxygenase inhibitor indomethacin without affecting the noradrenaline overflow (Fig. 6 ). In contrast, neither the 5'-lipoxygenase inhibitor nordihydroguaiaretic acid nor the leukotriene receptor antagonist N-(3-[3-(4-acetyl-3-hydroxy-1 H-tetrazole-Scarboxamide (CGP 35949 B) or the thromboxane receptor antagonist 4-[2-(4-chlorobenzene sulfonamide)ethyl]benzeneacetic acid (BM 13505) diminished the nerve effects [115] (Fig. 6 ). Prostaglandins FZo, Dz and E2, as well as the thromboxane A, analog U46619 (TXA2) and leukotrienes C4 and D4, the latter with a delay, increased glucose and lactate output in perfused liver [117-1201. However, only the prostaglandins, especially prostaglandin FZa, mimicked the effects elicited by the hepatic nerves in showing an 'escape phenomenon' (Fig. 7) , that is metabolite output started to return to values observed before stimulation, despite continued stimulation [117] . The delay in the metabolic actions of TXAz, leukotrienes C4 and D4 was the result of two opposing effects; the perfused parenchyma and thus metabolite output was reduced. This reduction was later compensated for by an increase in metabolism in the parenchymal cells which were still perfused. After cessation of the TXA2, leukotriene C4 or leukotriene D4 application, previously unperfused areas of the liver where reperfused and glucose and lactate, accumulated in the sinusoids, were washed out.
These observations, together with the data obtained in the inhibitor studies, suggested that prostaglandins, but not thromboxanes or leukotrienes, played a role in the signal chain of events after nerve stimulation. This view gains further support from the comparison of different inhibitors on the action of nerve stimulation and prostaglandin Fza (Fig. 6) . As with nerve stimulation, nordihydroguaiaretic acid, leukotriene and thromboxane receptor antagonists did not attenuate the prostaglandin F2,-elicited increase in metabolite output, nor did prazosin, bromophenacylbromide or nifedipine (see be-
The participation of prostaglandins in a signal chain of events from the nerve cell to the hepatocyte depends upon the existence of hepatocellular prostaglandin receptors. Evidence for the existence of such a receptor has accumulated. Prostaglandin F2. [121] , E2 [I221 and D, [123] stimulated glycogen phosphorylase activity or glucose release in hepatocyte suspensions, whereas the TXAz was inactive [121] . As in liver perfusions, half-maximal stimulation of glycogenolysis was observed in the concentration range 0.5 -5 pM for all three prostaglandins (Piischel, G. P., Schroder, A. and Jungermann, K., unpublished results). The prostaglandins increased inosito1 1,4,5-trisphosphate but not CAMP [121, 1221. A common low affinity binding site with a Kd of about 2 pM could be demonstrated in hepatocyte plasma membranes besides a prostaglandin F,,-specific high-affinity binding site, for which a biological function is currently not evident (NeuschaferRube, F., Piischel, G. P. and Jungermann, K., unpublished results). In other studies with hepatocyte suspensions, prostaglandin D2 stimulated glycogenolysis half-maximally at concentrations of 20 nM and a prostaglandin D2-specific binding site with a Kd in the same concentration range was described low). [123] .
Hemodynamics
Noradrenaline action. The nerve-stimulation-mediated flow reduction was inhibited almost completely by the areceptor antagonist phentolamine [73] , and the al-receptorspecific antagonist prazosin (Fig. 6) [74], but not by u2-receptor, P,-receptor and fi2-receptor blockers [75] and hence was mediated via u1 receptors. This could point to a direct contact of the nerve endings with the vascular smooth muscle cells regulating the flow.
involvement of eicosanoids. Flow reduction was also inhibited by the phospholipase A,/prostaglandin D2-synthesisinhibitor bromophenacylbromide (Fig. 6 ) and by the cyclooxygenase inhibitor indomethacine [99, 11 51. Thus, the possibility can be envisaged that the nervous regulation of liver hemodynamics was at least partly mediated via stimulation of eicosanoid formation in non-parenchymal liver cells. As with the metabolic effects of nerve stimulation, neither nordihydroguaiaretic acid nor leukotriene or thromboxane receptor antagonists [118] interfered with flow reduction to a significant extent (Fig. 6) , indicating that only prostaglandins, but not thromboxanes or leukotrienes, participated in flow regulation by the sympathetic hepatic nerves. Prostaglandins, especially prostaglandin F2,, mimicked the nerve-stimulationmediated flow reduction in kinetics and extent [117] . Bromophenacylbromide and, in contrast to nerve stimulation, also thromboxane-receptor and leukotriene-receptor antagonists (Iwai, M. and Jungermann, K., unpublished results), attenuated the prostaglandin F,,-elicited flow reduction slightly but significantly (Fig. 6 ). This might indicate that the flow effects of circulating prostaglandin F,,, in contrast to those of prostaglandin F,, released locally after nerve stimulation, could in part act via stimulation of leukotriene and thromboxane production in other non-parenchymal liver cells. Prazosin did not alter the prostaglandin F2,-mediated flow reduction, but the calcium channel blocker nifedipine abolished it [98, 11 81 (see below) . 
Hypothetical signal chain from nerve endings to the effector cells
The model. Since the metabolic and hemodynamic effects of hepatic nerve stimulation were inhibited by the ul-receptor blocker prazosin and by bromophenacylbromide or indomethacin, and since the actions of prostaglandin FZiT are unaffected by prazosin, noradrenaline and the u1 receptor must preceed prostaglandin and the prostaglandin receptor in the signal chain. Noradrenaline released from periportally located nerve endings might act partly via a1 receptors on nearby hepatocytes or partly via a, receptors on nonparenchymal liver cells, which in turn can release prostaglandins. Noradrenaline and prostaglandins would then stimulate glycogenolysis in neighbouring hepatocytes. The signal might be further propagated to more distant hepatocytes via gap junctions (Fig. 8) , which have been shown to be permeable to inositol1,4,5-trisphosphate and Ca2+. In freshly isolated pairs or clusters of hepatocytes, signal propagation was mediated by the transjunctional flux of these intracellular messengers [ 1241. Similarly, noradrenaline released from nerve endings might act partly via a1 receptors on smooth muscle cells of the hepatic blood vessels and partly via al receptors on nonparenchymal liver cells, which in turn could release prostaglandins. Again, noradrenaline and prostaglandin would then cause a constriction of the sinusoids (Fig. 8) .
Caveats to the model. The studies with inhibitors of eicosanoid synthesis do not prove the model, since inhibition might be caused by yet unknown unspecific side effects of these drugs. The model could be further supported by a prostanoid overflow into the hepatic vein, as has been shown after infusion of nucleotides, nucleosides, zymosan, endotoxin, aggregated immunoglobulins, anaphylatoxins, phorbol esters and calcium ionophores (see above) that stimulate glucose output and reduce flow in perfused livers. Such an overflow has not yet been demonstrated in a convincing manner after nerve stimulation. The overflow of prostaglandin Dz and prostaglandin E2 [lo61 was at the edge of significance and with concentrations of 2.5 nM and 0.1 nM far below the range in which physiological responses to prostaglandins have been observed. One has, however, to keep in mind that the overflow is only the difference between prostaglandin formation and degradation during the passage through the sinusoids. In fact, prostagbandins are very efficiently degraded by the liver. Thus, 90 -95% of prostaglandin Ez was extracted during a single passage through the sinusoids in rat liver perfused with defibrinated blood [125] and more than 95% of prostaglandin Fza immunoreactivity was eliminated during one passage through livers perfused with a Krebs-Henseleit buffer (Puschel, G. P., Hulsmann, M. and Jungermann, K., unpublished results). Taking into account that nerve action, in contrast to the circulating agents mentioned above, probably stimulates only a few periportally located non-parenchymal liver cells to release prostaglandins, a small or even lacking prostaglandin overflow does not argue against the participation of prostaglandins in the signal chain of events. In order to be a link in the signal chain of events from the nerve to the effector cell, non-parenchymal liver cells should possess a receptors and should react to stimulation by a agonists with prostaglandin formation. This has not yet been shown. Studies tempting to elucidate this are under way.
Signal chain within the effector cell
Metabolism
Following stimulation of the hepatic nerves, the activity of glycogen phosphorylase increased, that of glycogen synthase decreased and that of glycolytic pyruvate kinase remained unaffected. The level of the activators of glycogenolysis (CAMP) and glycolysis (fructose-2,6-bisphosphate), increased slightly [96] . The slight increase in CAMP could not account for the increase in glycogen phosphorylase activity. Therefore, it was assumed that liver nerves enhanced hepatic glucose output via an increase in the cytosolic calcium concentration (Fig. 9) . A transient release of Ca2+ into the perfusate, followed by a prolonged reuptake of Ca2+ after nerve stimulation favoured this view [77] . There was no evidence for entry of extracellular calcium via nifedipine-sensitive calcium channels [98] .
The possible involvement of intracellular calcium in the 'metabolic' signal chain of events was tested in 'calcium deprivation/replenishment' experiments [96] . The idea was that intracellular calcium pools should be emptied during a prolonged calcium-free perfusion and, thus, processes depending on intracellular calcium should be inhibited. After re- addition of calcium to the extracellular medium, processes depending on intracellular calcium should still be inhibited or at least delayed, since replenishment of intracellular calcium pools is a relatively slow process, lasting 2 -3 min. Processes depending on extracellular calcium, however, should be possible immediately after adding calcium to the medium. In calcium-free perfusions, nerve-stimulation-dependent metabolic alterations occurred with normal kinetics when calcium was added 3 min prior to stimulation; they were, however, delayed when calcium was added only 2 min after the onset of stimulation. This indicated that calcium release from intracellular pools was involved in the signal chain [96] (Fig. 9) . The second messenger causing a release of calcium from intracellular pools is generally thought to be inositol 1,4,5-trisphosphate, which, together with diacylglycerol, is released from phosphatidyl inositol4,S-bisphosphate after stimulation of a1 receptors. Both noradrenaline [126, 127] and prostaglandins [121, 1221 have been shown to increase inositol 1,4,5-trisphosphate in hepatocytes. In perfused livers, however, a significant increase in inositol 1,4,5-trisphosphate could not be demonstrated after nerve stimulation, but only after infusion of noradrenaline [128] . This result would fit the hypothesis that, during nerve action, only a few periportal hepatocytes are directly stimulated by noradrenaline or prostaglandins, leading to a small local increase in inositol 1,4,5-trisphosphate which is not measurable in whole liver homogenates, and that the signal is then propagated to the majority of hepatocytes via gap junctions (Fig. 8) .
The metabolic nerve actions were inhibited by so-called calcium-releasing hormones such as adrenaline, noradrenaline [89] , vasopressin and angiotensin (Miura, H., Gardemann, A., Rosa, J. and Jungermann, K., unpublished results) (Fig. 9) , which increase inositol 1,4,5-trisphosphate and diacylglycerol, and by high concentrations of the phorbol ester 4P-phorbol 12-myristate 13-acetate. Diacylglycerol and 4P-phorbol 12-myristate 13-acetate would activate protein kinase C, which is known to inhibit the al-receptor-mediated hydrolysis of phosphatidyl inositol 4,5-bisphosphate to inositol 1,4,5-Blood Glucose trisphosphate [129] . These findings would corroborate the participation of inositol 1,4,5-trisphosphate in the nerve-signal chain of reactions.
Hemodynamics. The hemodynamic nerve effects were inhibited by the calcium-channel blocker nifedipine (Fig. 6) [98] . In the 'calcium deprivation/replenishment' experiments, the nerve-stimulation-mediated flow reduction was restored immediately after readdition of calcium [96] . Thus, the hemodynamic nerve effects were dependent on the entry of extracellular calcium into the smooth muscle cells. Within the cell, Ca2 + would activate the calmodulin-dependent myosin light chain kinase and thus cause constriction. The attenuation of the flow effects by sodium nitroprusside [73] , which decreases the sensitivity of the system to calmodulin by increasing cGMP, would also be in line with this mechanism.
Functions of sympathetic and parasympathetic nerve actions
The liver is both the central organ for the maintenance of the energy supply, mainly by operating as a glucostat and also an active and passive blood reservoir 16, 71 (Table 1) . A network of afferent and efferent, sympathetic and Parasympathetic nerves is important for the regulation of the glucose and blood reservoir function of the liver. The network senses the blood glucose concentration and blood pressure [25, 26, [66] [67] [68] [69] [70] [71] [72] and influences hepatic metabolism and hemodynamics directly via liver nerves and indirectly via modifying the hormonal secretion rates of other organs, such as the pancreas and adrenal medulla (Fig. 10) .
Activation of the sympathetic nervous system signals that the organism requires glucose and blood. The total amount of glucose and part of the required blood are provided by the liver in which some tissue areas release blood to the circulation by being squeezed out and temporarily restricted from receiving further blood supply and in which other tissue areas remain accessible mainly for the increased release of systemically 409 required glucose. Major signals for an increase in glucose output are declining glucose levels, increased portovenous concentrations of glucagon, enhanced systemic levels of catecholamines and an increased tone of the sympathetic liver nerves. Major signals for release of blood are elevated concentrations of circulating catecholamines and again an increased tone of the sympathetic hepatic nerves. Thus, the sympathetic nervous system, activated in part via afferent hepatic nerve fibers [25, 26, [66] [67] [68] [69] [70] [71] [72] , appears to control the glucose and the blood-reservoir functions mainly directly via sympathetic liver nerves and also indirectly by activating the release of glucagon from the pancreas and of adrenaline and noradrenaline from the adrenal medulla (Fig. 10) .
After a normal meal, the liver takes up a substantial part of the absorbed glucose. Major signals for the activation of glucose uptake are an increased glucose concentration gradient between the portal vein and the hepatic artery [130] , an increased portovenous level of insulin and an enhanced tone of the parasympathetic liver nerves. The parasympathetic nervous system enhances hepatic glucose uptake indirectly by stimulation of insulin release and reduction of the activity of the hepatic branch of efferent splanchnic nerve fibers [69] and of the level of circulating catecholamines as well as directly via the hepatic nerves antagonistically to glucagon and synergistically with insulin ( Fig. 10) [95] .
